Journals / Türkiye Çocuk Hastalıkları Dergisi / 2020 / Cilt: 14 - Sayı: 3

The Effect of Mefv Gene Mutatıons in Patients With PFAPA Syndrome

PFAPA Sendromunda Mefv Gen Mutasyonlarının Hastalık Üzerine Etkisi

Pages
258–263
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The duration and frequency of attacks were more frequently in patients with PFAPA carrying the MEFV gene mutation compared to the patients without mutation (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is a condition characterized by recurrent episodes of fever accompanied by aphthous stomatitis, cervical adenitis, and pharyngitis.
📊
Key Findings & Data:Our country is one of the communities with the highest number of familial Mediterranean fever carriers worldwide, with a rate of 1/5.
💡
Conclusion & Impact:Results: The duration and frequency of attacks were more frequently in patients with PFAPA carrying the MEFV gene mutation compared to the patients without mutation (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is a condition characterized by recurrent episodes of fever accompanied by aphthous stomatitis, cervical adenitis, and pharyngitis. The absence of underlying hematological disorder and/or upper respiratory tract infections is mandatory for confirmation of PFAPA syndrome diagnosis. There is no specific laboratory test confirming a diagnosis of PFAPA syndrome. Our country is one of the communities with the highest number of familial Mediterranean fever carriers worldwide, with a rate of 1/5. It is well known that this high carriage increases the severity of various rheumatic diseases such as rheumatoid arthritis, ankylosing spondylitis, PFAPA syndrome. In this study, it was aimed to investigate the effect of familial Mediterranean fever carriage on clinical and laboratory findings, disease course and severity in children with PFAPA syndrome. Material and Methods: The cohort consisted of 70 children with PFAPA syndrome who were tested for MEFV gene mutations. Demographic data, clinical findings, attack frequency and duration, laboratory values (leukocyte count, erythrocyte sedimentation rate, C reactive protein), MEFV gene analysis results were recorded to pre-prepared forms. Demographic variables, clinical characteristics, and disease course of 33 PFAPA patients with and 37 without MEFV gene mutations were compared. Results: The duration and frequency of attacks were more frequently in patients with PFAPA carrying the MEFV gene mutation compared to the patients without mutation (p

Özet

Amaç: Kalıtsal olmayan otoinflamatuvar hastalıklardan biri olarak sınıflandırılan PFAPA (Periodic fever, apthous stomatitis,pharyngitis and cervical adenitis) sendromu; periyodik ateş, farenjit, servikal lenfadenit ve stomatit ile seyretmektedir.Altta yatan hematolojik bozukluk ve/veya üst solunum yolu enfeksiyonlarının olmaması, PFAPA sendromu tanısınındoğrulanması için zorunludur. Hastalığa tanı koydurucu özgül bir laboratuvar belirteci bulunmamaktadır. Ülkemiz 1/5taşıyıcılık oranı ile dünya üzerinde ailesel Akdeniz ateşi taşıyıcılığının en fazla olduğu toplumlardan birisidir. Bu yüksektaşıyıcılığın romatoid artrit, ankilozan spondilit, PFAPA sendromu gibi çeşitli romatizmal hastalıkların şiddetini arttırdığıiyi bilinmektedir. Bu çalışmada ailesel Akdeniz ateşi taşıyıcılığının PFAPA sendromlu çocuklarda klinik ve laboratuvarbulguları, hastalık seyri ve şiddeti üzerindeki etkisini araştırmak amaçlanmıştır.Gereç ve Yöntemler: Çalışmaya PFAPA sendromu tanısı konulmuş ve MEFV gen analizi gönderilmiş 70 hasta dahiledilmiştir. Hastaların demografik verileri, klinik bulguları, atak sayısı ve şiddeti, atakta laboratuvar değerleri (lökosit sayısı,eritrosit sedimentasyon hızı, C reaktif protein), MEFV gen analiz sonuçları önceden hazırlanmış formlara kaydedilmiştir.MEFV gen mutasyonu pozitif olan 33 hasta ile MEFV gen mutasyonu negatif olan 37 hasta demografik veriler, kliniközellikler ve hastalık seyri açısından karşılaştırılmıştır.Bulgular: MEFV gen mutasyonu taşıyan PFAPA’lı hastalarda atak süresi ve sıklığı mutasyon taşımayan hastalara göredaha fazlaydı (p

🔖

Cite This Article

BÜLBÜL, M., ÖZDEL, S., BAĞLAN, E. (2022). The Effect of Mefv Gene Mutatıons in Patients With PFAPA Syndrome. Türkiye Çocuk Hastalıkları Dergisi, Cilt: 14 - Sayı: 3, 258–263. https://ajindex.com/articles/627123

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Marshall GS, Edwards KM, Lawton AR. PFAPA syndrome. Pediatr Infect Dis J 1989; 8:658-9
  2. Theodoropoulou K, Vanoni F, Hofer M. Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome: a Review of the Pathogenesis. Curr Rheumatol Rep 2016;18:18
  3. Adrovic A, Sahin S, Barut K, Kasapcopur O. Familial Mediterranean fever and periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: shared features and main differences. Rheumatol Int 2019; 39:29–36
  4. Padeh S, Brezniak N, Zemer D, Pras E, Livneh A, Langevitz P, Migdal A, Pras M, Passwell JH. Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr 1999; 135:98–101
  5. Hofer M, Pillet P, Cochard MM, Berg S, Krol P, Kone-Paut I, Rigante D, et al. International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients. Rheumatology (Oxford) 2014; 53:1125–9
  6. Pehlivan E, Adrovic A, Sahin S, Barut K, Kul Cinar O, Kasapcopur O. PFAPA syndrome in a population with endemic familial Mediterranean fever. J Pediatr 2018; 192:253–5
  7. Barut K, Sahin S, Adrovic A, Sinoplu AB, Yucel G, Pamuk G, et al. Familial Mediterranean fever in childhood: a single-center experience. Rheumatol Int 2018; 38:67–74
  8. Özen S, Batu ED, Demir S. Familial Mediterranean fever: recent developments in pathogenesis and new recommendations for management. Front Immunol 2017; 8:253
  9. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, et al. Familial Mediterranean fever (FMF) in Turkey: Results of a nationwide multicenter study. Medicine (Baltimore) 2005; 84: 1-11
  10. French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 25-31
  11. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 1997; 90: 797-807
  12. Chae JJ, Wood G, Richard K, Jaffe H, Colburn NT, Masters SL, et al. The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood 2008; 112:1794-803
  13. Berkun Y, Ben-Chetrit E. Pyrin and cryopyrin—similar domain sequence but opposite inflammatory consequence. Clin Exp Rheumatol 2007;25(4 Suppl 45): S6-8
  14. Rabinovich E, Livneh A, Langevitz P, Brezniak N, Shinar E, Pras M, et al. Severe disease in patients wit